Growth Metrics

Alector (ALEC) Depreciation & Amortization (CF) (2018 - 2026)

Alector (ALEC) reported Depreciation & Amortization (CF) of $1.1 million for Q1 2026, up 9.86% year-over-year from $984000.0 in Q1 2025, and down 7.45% on a QoQ basis from $1.2 million in Q4 2025.

Alector (ALEC) has 9 years of Depreciation & Amortization (CF) data on file, last reported at $1.1 million in Q1 2026.

  • Quarterly Depreciation & Amortization (CF) rose 9.86% year-over-year to $1.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $5.8 million (up 17.52% YoY) and the FY2025 annual result came in at $5.7 million, up 5.75% from the prior year.
  • Depreciation & Amortization (CF) retreated to $1.1 million in Q1 2026 per ALEC's latest filing, from $1.2 million in the prior quarter.
  • Across five years, Depreciation & Amortization (CF) topped out at $2.3 million in Q2 2025 and bottomed at $984000.0 in Q1 2025.
  • The 5-year median for Depreciation & Amortization (CF) is $1.4 million (2022), against an average of $1.4 million.
  • Peak annual rise in Depreciation & Amortization (CF) reached 65.88% in 2025, while the deepest fall reached 31.81% in 2025.
  • Tracing ALEC's Depreciation & Amortization (CF) over 5 years: stood at $1.4 million in 2022, then advanced by 3.08% to $1.4 million in 2023, then declined by 13.57% to $1.2 million in 2024, then decreased by 5.96% to $1.2 million in 2025, then fell by 7.45% to $1.1 million in 2026.
  • Per Business Quant, the three latest ALEC Depreciation & Amortization (CF) figures stand at $1.1 million (Q1 2026), $1.2 million (Q4 2025), and $1.2 million (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Depreciation & Amortization (Qtr)
1 Quantum Biopharma 1,216,509.61 Bn 1,216,509.61 Bn - -
2 Alterity Therapeutics 764,224.41 Bn 764,224.38 Bn - 1,395.22
3 Legend Biotech 2,716.00 Bn 2,715.71 Bn 242.10 Mn -
4 Nanobiotix 2,248.83 Bn 2,248.77 Bn - -
5 Akari Therapeutics 1,951.18 Bn 1,951.17 Bn - -
6 Vertex Pharmaceuticals 113.69 Bn 106.44 Bn 2.59 Bn 55.90 Mn
7 Evaxion A 64.16 Bn 64.14 Bn - -
8 Regeneron Pharmaceuticals 63.94 Bn 55.18 Bn 3.31 Bn 123.20 Mn
9 Alnylam Pharmaceuticals 40.13 Bn 37.12 Bn 959.66 Mn 13.55 Mn
10 Alector 238.87 Mn 32.36 Mn - 1.08 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 1.08 Mn
Mar 31, 2026 1.08 Mn
Dec 31, 2025 1.17 Mn
Dec 31, 2025 1.17 Mn
Sep 30, 2025 1.24 Mn
Sep 30, 2025 1.24 Mn
Jun 30, 2025 2.33 Mn
Jun 30, 2025 2.33 Mn
Mar 31, 2025 984,000.00
Mar 31, 2025 984,000.00
Dec 31, 2024 1.24 Mn
Dec 31, 2024 1.24 Mn
Sep 30, 2024 1.32 Mn
Sep 30, 2024 1.32 Mn
Jun 30, 2024 1.40 Mn
Jun 30, 2024 1.40 Mn
Mar 31, 2024 1.44 Mn
Mar 31, 2024 1.44 Mn
Dec 31, 2023 1.44 Mn
Dec 31, 2023 1.44 Mn
Sep 30, 2023 1.46 Mn
Sep 30, 2023 1.46 Mn
Jun 30, 2023 1.46 Mn
Jun 30, 2023 1.46 Mn
Mar 31, 2023 1.36 Mn
Mar 31, 2023 1.36 Mn
Dec 31, 2022 1.39 Mn
Dec 31, 2022 1.39 Mn
Sep 30, 2022 1.35 Mn
Sep 30, 2022 1.35 Mn
Jun 30, 2022 1.38 Mn
Jun 30, 2022 1.38 Mn
Mar 31, 2022 1.59 Mn
Mar 31, 2022 1.59 Mn
Dec 31, 2021 1.59 Mn
Dec 31, 2021 1.59 Mn
Sep 30, 2021 1.61 Mn
Sep 30, 2021 1.61 Mn
Jun 30, 2021 1.59 Mn
Jun 30, 2021 1.59 Mn
Mar 31, 2021 1.54 Mn
Mar 31, 2021 1.54 Mn
Dec 31, 2020 1.50 Mn
Dec 31, 2020 1.50 Mn
Sep 30, 2020 1.46 Mn
Sep 30, 2020 1.46 Mn
Jun 30, 2020 1.46 Mn
Jun 30, 2020 1.46 Mn
Mar 31, 2020 1.45 Mn
Mar 31, 2020 1.45 Mn
Dec 31, 2019 1.38 Mn
Dec 31, 2019 1.38 Mn
Sep 30, 2019 1.28 Mn
Sep 30, 2019 1.28 Mn
Jun 30, 2019 821,000.00
Jun 30, 2019 821,000.00
Mar 31, 2019 298,000.00
Mar 31, 2019 298,000.00
Dec 31, 2018 276,000.00
Dec 31, 2018 276,000.00
Sep 30, 2018 279,000.00
Sep 30, 2018 279,000.00
Jun 30, 2018 252,000.00
Jun 30, 2018 252,000.00
Mar 31, 2018 212,000.00
Mar 31, 2018 212,000.00